Analysis of HIV Diversity in HIV-Infected Black Men Who Have Sex with Men (HPTN 061)

Background HIV populations often diversify in response to selective pressures, such as the immune response and antiretroviral drug use. We analyzed HIV diversity in Black men who have sex with men who were enrolled in the HIV Prevention Trials Network 061 study. Methods A high resolution melting (HRM) diversity assay was used to measure diversity in six regions of the HIV genome: two in gag, one in pol, and three in env. HIV diversity was analyzed for 146 men who were HIV infected at study enrollment, including three with acute infection and 13 with recent infection (identified using a multi-assay algorithm), and for 21 men who seroconverted during the study. HIV diversification was analyzed in a paired analysis for 62 HIV-infected men using plasma samples from the enrollment and 12-month (end of study) visits. Results Men with acute or recent infection at enrollment and seroconverters had lower median HRM scores (lower HIV diversity) than men with non-recent infection in all six regions analyzed. In univariate analyses, younger age, higher CD4 cell count, and HIV drug resistance were associated with lower median HRM scores in multiple regions; ARV drug detection was marginally associated with lower diversity in the pol region. In multivariate analysis, acute or recent infection (all six regions) and HIV drug resistance (both gag regions) were associated with lower median HRM scores. Diversification in the pol region over 12 months was greater for men with acute or recent infection, higher CD4 cell count, and lower HIV viral load at study enrollment. Conclusions HIV diversity was significantly associated with duration of HIV infection, and lower gag diversity was observed in men who had HIV drug resistance. HIV pol diversification was more pronounced in men with acute or recent infection, higher CD4 cell count, and lower HIV viral load.

[1]  Jan Albert,et al.  Population genomics of intrapatient HIV-1 evolution , 2015, eLife.

[2]  O. Laeyendecker,et al.  Antiretroviral Drug Use and HIV Drug Resistance Among HIV-Infected Black Men Who Have Sex With Men: HIV Prevention Trials Network 061 , 2015, Journal of acquired immune deficiency syndromes.

[3]  S. Buchbinder,et al.  Low-Level Viremia Early in HIV Infection , 2014, Journal of acquired immune deficiency syndromes.

[4]  S. Buchbinder,et al.  Concomitant Socioeconomic, Behavioral, and Biological Factors Associated with the Disproportionate HIV Infection Burden among Black Men Who Have Sex with Men in 6 U.S. Cities , 2014, PloS one.

[5]  R. Siliciano,et al.  Association of pol Diversity with Antiretroviral Treatment Outcomes among HIV-Infected African Children , 2013, PloS one.

[6]  Sikhulile Moyo,et al.  Intra-host evolutionary rates in HIV-1C env and gag during primary infection. , 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[7]  S. Buchbinder,et al.  Correlates of HIV Acquisition in a Cohort of Black Men Who Have Sex with Men in the United States: HIV Prevention Trials Network (HPTN) 061 , 2013, PloS one.

[8]  R. Stephens,et al.  HIV Populations Are Large and Accumulate High Genetic Diversity in a Nonlinear Fashion , 2013, Journal of Virology.

[9]  Richard D Moore,et al.  Antibody Maturation and Viral Diversification in HIV-Infected Women , 2013, PloS one.

[10]  Oliver Laeyendecker,et al.  Estimation of HIV incidence using multiple biomarkers. , 2013, American journal of epidemiology.

[11]  Susan H. Eshleman,et al.  Analysis of HIV Using a High Resolution Melting (HRM) Diversity Assay: Automation of HRM Data Analysis Enhances the Utility of the Assay for Analysis of HIV Incidence , 2012, PloS one.

[12]  P. Musoke,et al.  Use of a High Resolution Melting Assay to Analyze HIV Diversity in HIV-infected Ugandan Children , 2012, The Pediatric infectious disease journal.

[13]  T. Quinn,et al.  Comparison of a High-Resolution Melting Assay to Next-Generation Sequencing for Analysis of HIV Diversity , 2012, Journal of Clinical Microbiology.

[14]  Richard D Moore,et al.  Use of a High Resolution Melting (HRM) Assay to Compare Gag, Pol, and Env Diversity in Adults with Different Stages of HIV Infection , 2011, PloS one.

[15]  Lei Wang,et al.  Association of HIV Diversity and Survival in HIV-Infected Ugandan Infants , 2011, PloS one.

[16]  S. Ray,et al.  Analysis of HIV diversity using a high-resolution melting assay. , 2010, AIDS research and human retroviruses.

[17]  B. Keele,et al.  Identifying and characterizing recently transmitted viruses , 2010, Current opinion in HIV and AIDS.

[18]  Alan S. Perelson,et al.  High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men , 2010, PLoS pathogens.

[19]  Y. Tu,et al.  Evolution of HIV‐1 in a patient population failing multiple‐drug therapy , 2009, Microbiology and immunology.

[20]  J. Baeten,et al.  HIV-1 evolution in gag and env is highly correlated but exhibits different relationships with viral load and the immune response , 2009, AIDS.

[21]  T. Ross,et al.  Viral sequence diversity: challenges for AIDS vaccine designs , 2008, Expert review of vaccines.

[22]  Hui Li,et al.  Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection , 2008, Proceedings of the National Academy of Sciences.

[23]  C. Brander,et al.  HIV viral diversity and escape from cellular immunity , 2007, Current infectious disease reports.

[24]  Sergei L. Kosakovsky Pond,et al.  Synonymous Substitution Rates Predict HIV Disease Progression as a Result of Underlying Replication Dynamics , 2007, PLoS Comput. Biol..

[25]  J. Overbaugh,et al.  Diversity in HIV-1 envelope V1-V3 sequences early in infection reflects sequence diversity throughout the HIV-1 genome but does not predict the extent of sequence diversity during chronic infection. , 2006, AIDS research and human retroviruses.

[26]  A. Trkola,et al.  Low Human Immunodeficiency Virus Envelope Diversity Correlates with Low In Vitro Replication Capacity and Predicts Spontaneous Control of Plasma Viremia after Treatment Interruptions , 2005, Journal of Virology.

[27]  S. Williamson,et al.  Adaptation in the env gene of HIV-1 and evolutionary theories of disease progression. , 2003, Molecular biology and evolution.

[28]  P. Gilbert,et al.  Intrapatient Diversity and Its Correlation with Viral Setpoint in Human Immunodeficiency Virus Type 1 CRF02_A/G-IbNG Infection , 2002, Journal of Virology.

[29]  D. Richman,et al.  HIV-1 neutralizing antibody response and viral genetic diversity characterized with next generation sequencing. , 2015, Virology.

[30]  S. Buchbinder,et al.  Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  D. Donnell,et al.  Impact of mutation type and amplicon characteristics on genetic diversity measures generated using a high-resolution melting diversity assay. , 2013, The Journal of molecular diagnostics : JMD.

[32]  D. Richman,et al.  HIV evolution and escape. , 2004, Transactions of the American Clinical and Climatological Association.

[33]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .